Darwin Global Management, Ltd. 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-28 4:45 pm Purchase |
2023-06-27 | 13D | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 116,820,452 27.500% |
37,688,441 (+47.63%) |
Filing |
| 2023-05-25 4:39 pm Unchanged |
2023-05-23 | 13D | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 79,132,011 20.500% |
0 (Unchanged) |
Filing |
| 2023-03-08 10:49 am Purchase |
2023-03-06 | 13D | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 79,132,011 26.400% |
26,040,588 (+49.05%) |
Filing |
| 2023-02-14 09:30 am Purchase |
2022-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 53,091,423 19.600% |
2,450,000 (+4.84%) |
Filing |
| 2022-12-19 08:30 am Purchase |
2022-12-09 | 13G | Ambrx Biopharma Inc. AMAM |
Darwin Global Management, Ltd. | 50,641,423 18.700% |
50,641,423 (New Position) |
Filing |